nandrolone undecanoate profile

Following oral administration, the drug is absorbed nandrolone undecanoate profile from the gastrointestinal tract, the maximum plasma concentration observed after an average of 2 hours after administration. It is metabolized in the liver and partly excreted unchanged in the urine and bile.



  • chronic venous insufficiency;
  • trophic disorders in patients with chronic venous insufficiency (dermatitis, trophic ulcers);
  • phlebeurysm;
  • superficial thrombophlebitis, periflebit;
  • post-thrombotic syndrome;
  • post-traumatic edema, hematoma;
  • hemorrhoids;
  • diabetic angiopathy, retinopathy.Contraindications:
    Hypersensitivity to the drug; nandrolone undecanoate profile gastric ulcer and duodenal ulcer, chronic gastritis (exacerbation), pregnancy (I trimester), lactation, children under 18 years (including the dosing regimen).

    Precautions should be used drug (prolonged use) with renal failure.

    Use of the drug during pregnancy and breast-feeding
    Caution should be used Troxerutin Zentiva during pregnancy, the possibility of use of the drug during pregnancy is determined by your doctor, do not use the drug during breastfeeding.

    Dosing and Administration
    Inside. The capsules should be swallowed whole during a meal.
    Troxerutin Zentiva is used on doctor’s prescription. Typically prescribed 1 capsule orally 3 times a day; as maintenance therapy -. 1 capsule 2 times a day
    course of treatment an average of 3-4 weeks, the need for more long-term treatment is determined individually.

    Side effects:
    headache, irritation of the gastrointestinal tract, allergic reactions (including skin rashes and itching).

    In case of overdose may cause the following symptoms: agitation, nausea, headache and flushing. In case of overdose patients should wash the stomach, take activated charcoal, consult a doctor. If necessary, symptomatic treatment.

    Vzamodeystviya with other drugs
    In an application enhances the effect of ascorbic acid on the structure and permeability of the vascular wall.

    Special instructions:
    The drug Troxerutin Zentiva does not affect the motor and mental reactions, does not interfere with driving and operating machinery.
    Experience with the drug in children under the age of 15 years is missing.
    In the treatment of superficial thrombophlebitis or deep vein thrombosis drug application Troxerutin Zentiva not eliminating the need nandrolone undecanoate profile for anti-purpose funds and antithrombotic therapy.